Douglas Ross
2022
In 2022, Douglas Ross earned a total compensation of $1.1M as Former Chief Science Officer at Oncocyte Corp, a 30% decrease compared to previous year.
Compensation breakdown
| Option Awards | $186,990 |
|---|---|
| Salary | $359,135 |
| Stock Awards | $201,750 |
| Other | $400,775 |
| Total | $1,148,649 |
Ross received $400.8K in other compensation, accounting for 35% of the total pay in 2022.
Ross also received $187K in option awards, $359.1K in salary and $201.8K in stock awards.
Rankings
In 2022, Douglas Ross' compensation ranked 2,769th out of 5,756 executives tracked by ExecPay. In other words, Ross earned more than 51.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,769 out of 5,756 | 52nd |
Division Manufacturing | 1,539 out of 3,133 | 51st |
Major group Chemicals And Allied Products | 714 out of 1,419 | 50th |
Industry group Drugs | 666 out of 1,320 | 50th |
Industry In Vitro and In Vivo Diagnostic Substances | 12 out of 29 | 59th |
Source: SEC filing on May 19, 2023.
Ross' colleagues
We found five more compensation records of executives who worked with Douglas Ross at Oncocyte Corp in 2022.
2022
Ronald Andrews
Oncocyte Corp
Chief Executive Officer
2022
Gisela Paulsen
Oncocyte Corp
Chief Operating Officer
2022
Anish John
Oncocyte Corp
Chief Financial Officer
2022
Joshua Riggs
Oncocyte Corp
Chief Executive Officer
2022
James Liu
Oncocyte Corp